[Guidelines for insulin pump therapy in children and adults].
This position statement is based on the cur-rent evidence available on the safety and benefits of continous subcutaneous insulin pump therapy (CSII) in diabetes mellitus with an emphasis on the effects of CSII on glycemic control, hypoglycaemia rates, occur-ance of ketoacidosis, quality of life and the use of insu-lin pump therapy in pregnancy. The current article rep-resents the recommendations of the Austrian Diabetes Association for the clinical praxis of insulin pump treat-ment in children and adults.
3. Medizinische Abteilung für Stoffwechselerkrankungen und Nephrologie, Krankenhaus Hietzing, Wien, Österreich. marietta.stadler@chello.at
Marietta
M
Stadler
Sandra
S
Zlamal-Fortunat
Ingrid
I
Schütz-Fuhrmann
Birgit
B
Rami-Merhar
Edith
E
Schober
Alexandra
A
Kautzky-Willer
Raimund
R
Weitgasser
Rudolf
R
Prager
Martin
M
Bischof
D000293:Adolescent; D000328:Adult; D001317:Austria; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy*; D016640:Diabetes, Gestational / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems / Q000592:standards*; D008297:Male; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D055815:Young Adult
D007004:Hypoglycemic Agents; D007328:Insulin